Emergency Use Authorization

Laurus has applied with CDSCO for EUA of the drug

ZyCoV-D’s Phase III interim analysis has shown efficacy of 66.6 per cent and was conducted in over 28,000 subjects, including 1000…

The COVID-19 vaccine has been tested in adolescent population in the 12-18 years age group in India as well

This is the first COVID-19 vaccine authorised in the US for use in this age group

Considering that it is a combination of two recombinant human immunoglobulin G-1 (IgG1) monoclonal antibodies, it is expected to…

The company expects to ship 40-50 million doses per month to the US Government to fulfill its commitments

The data package delivered includes interim efficacy and safety results from the Phase 3 ENSEMBLE clinical trial

As part of the review process, Dr Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3…

Lilly plans to manufacture more than 250,000 doses of the bamlanivimab and etesevimab therapy throughout Q1 2021, and up to a…

Lenzilumab, a monoclonal antibody, is designed to prevent and treat cytokine storm, a complication considered to be a leading…